SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-15-008350
Filing Date
2015-11-20
Accepted
2015-11-20 17:42:23
Documents
1
Period of Report
2015-11-18

Document Format Files

Seq Description Document Type Size
1 KOVNER/SNTA p6908047.html 4  
1 KOVNER/SNTA p6908047.xml 4 17639
  Complete submission text file 0000919574-15-008350.txt   18837
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAXTON ASSOCIATES 500 PARK AVENUE NEW YORK NY 10022
Business Address
Kovner Bruce (Reporting) CIK: 0001325713 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 151247668